title: Anticoagulation for stroke prevention in a Medicare population with atrial fibrillation.
authors.affiliation: Florida Medical Quality Assurance, Inc., USA.
authors.forename: L S
authors.initials: LS
authors.lastname: Miranda
authors.forename: R A
authors.initials: RA
authors.lastname: Turkel
authors.forename: O
authors.initials: O
authors.lastname: Ahmed
authors.forename: M
authors.initials: M
authors.lastname: Dent
authors.forename: C
authors.initials: C
authors.lastname: Dion
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D001780:Blood Coagulation Tests; D002545:Brain Ischemia / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D018890:Chemoprevention; D005260:Female; D005431:Florida; D006801:Humans; D008297:Male; D006278:Medicare; D008875:Middle Aged; D010353:Patient Education as Topic; D012737:Sex Factors; D014481:United States; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin